thiophenes has been researched along with Complication, Postoperative in 144 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (11.81) | 18.7374 |
1990's | 5 (3.47) | 18.2507 |
2000's | 31 (21.53) | 29.6817 |
2010's | 89 (61.81) | 24.3611 |
2020's | 2 (1.39) | 2.80 |
Authors | Studies |
---|---|
Bezuhly, M; Boudreau, C; Gareau, A; Jones, C; Legere, S; LeVatte, T | 1 |
Fan, N; Huang, L; Lan, C; Liu, G; Liu, X; Luo, X; Tan, J; Tang, L; Zhou, L; Zhu, Y | 1 |
Jeer, P; Rose, B; Saran, D; Shrivastava, R; Sindali, K; Soueid, H | 1 |
Guijarro Merino, R; Villalobos Sánchez, A | 1 |
Forster, MC; Goodson, MW; Rath, NK; White, SP | 1 |
Ageno, W; Buller, H; Glazer, S; Gunn, S; Peerlinck, K; Prins, M; Sonesson, E; Tangelder, M; Vanassche, T; Vandenbriele, C; Verhamme, P | 1 |
Alexopoulos, D; Davlouros, P; Hahalis, G; Perperis, A; Siapika, A; Stavrou, K; Tsoni, E; Xanthopoulou, I | 1 |
Jing, J; Li, J; Zhan, J; Zhou, Y | 1 |
Duprez, T; Hantson, P; Vinetti, M | 1 |
Douketis, J; Liew, A | 1 |
Díaz de Rada, P; González, AB; Muñoa, L; Valentí, A; Valentí, JR | 1 |
Chana, F; Llau, JV; Marco, P; Zamorano, JL | 1 |
Wanat, MA | 1 |
Acosta, J; Benezet, J; Cubero Gómez, JM; Díaz DE LA Llera, LS; Fernández-Cisnal, A; Parejo, J; Rangel, D; Zafra, F | 1 |
Brosa, M; Diamantopoulos, A; Folkerts, K; Imberti, D; Monreal, M | 1 |
Beatty, NC; Curry, TB; Eisenach, JH; Langman, LJ; Nicholson, WT | 1 |
Brennan, T; Canestaro, WJ; Chaplin, D; Choudhry, NK; Desai, NR; Kyrychenko, P; Martell, LA; Matlin, OS | 1 |
Aldin, ES; Greenberg, C; Rachidi, S; Sachs, B; Streiff, M; Zeidan, AM | 1 |
Dütsch, M; Klauser, W | 1 |
Baker, R; Herrmann, R; Muhammad, S; Phillips, M; Thom, J; Wood, A | 1 |
Jiang, B; Li, H; Long, A; Mao, Z; Tang, P; Xie, Z; Zhang, L; Zhang, S; Zhang, Y | 1 |
Atkins, D; Baheiry, S; Barrett, CD; Bommana, S; Burkhardt, JD; Chalhoub, F; Di Biase, L; Gangireddy, S; Lakkireddy, D; Mansour, MC; Natale, A; Reddy, V; Reddy, YM; Ruskin, J; Sanchez, JE; Santangeli, P; Swarup, V; Vallakati, A; Verma, A | 1 |
Angiolillo, DJ; Capodanno, D | 1 |
Meddahi, S; Samama, MM | 1 |
Jing, J; Li, J; Yao, Y; Zhan, J; Zhou, Y | 1 |
Jing, JH; Li, J; Shi, ZJ; Zhou, Y | 1 |
Du, S; Harenberg, J; Krämer, R; Krämer, S; Lip, GY; Schulze, A; Wehling, M; Weiss, C; Zolfaghari, S | 1 |
Hess, T; Konturek, P | 1 |
Fukamizu, S; Hiraoka, M; Kitamura, T; Sakurada, H | 1 |
Alexander, KP; Bagai, A; Bhatt, DL; Cheema, AN; Curtis, JP; Granger, CB; Gurm, HS; McNamara, RL; Peterson, ED; Roe, MT; Saucedo, JF; Shah, B; Wang, TY; Wang, Y | 1 |
Cong, X; Molloy, B | 1 |
Engel, G; Kong, MH; Mead, RH; Patrawala, RA; Winkle, RA | 1 |
Ikeda, Y; Isshiki, T; Kimura, T; Kitagawa, K; Miyazaki, S; Nakamura, M; Nanto, S; Nishikawa, M; Ogawa, H; Saito, S; Takayama, M; Yokoi, H | 1 |
Cui, J; Li, Z; Liu, C; Wu, B | 1 |
Bozhkova, SA; Drozdova, PV; Novokshonova, AA | 1 |
Ambrosoli, A; Cimminiello, C; Compagnone, C; Fanelli, A; Imberti, D; Ottani, F; Tripodi, A | 1 |
Berges, C; Chatterjee, M; Einsele, H; Topp, MS | 1 |
Henao-Guerrero, N; Herring, IP; Matusow, RB; Pickett, JP; Werre, SR | 1 |
Armour, MD; Dees, DD; Greller, A; Madsen, R; Paglia, D; Spahn, KJ; Wagner, LS | 1 |
Eikelboom, JW; Weitz, JI | 1 |
Oberpichler-Schwenk, H | 1 |
Ferrandis, R; Llau, JV; López Forte, C; Sapena, ML | 1 |
Mantz, J | 1 |
Laporte, S; Mismetti, P | 1 |
Samama, CM | 2 |
Arnaout, L; Bellamy, L; Chabbouh, T; Rosencher, N | 1 |
Albaladejo, P | 1 |
Drouet, L | 1 |
Bounameaux, H | 1 |
Borris, LC | 2 |
Crowther, MA; Lepic, K | 1 |
Blázquez-Pérez, A; Gómez-Outes, A; Pozo-Hernández, C; Suárez-Gea, ML; Vargas-Castrillón, E | 1 |
Holmes, M; Kaltenthaler, E; Rees, A; Scope, A; Stevenson, M | 1 |
Collet, JP; Montalescot, G | 1 |
Deardorff, RL; Ikonomidis, JS; Mulcahy, J; Spinale, FG; Szeto, WY; Toole, JM; Zellner, JL | 1 |
Verma, AK | 1 |
Dick, W; Saxer, F | 1 |
Feng, JB; Ge, SL; Gong, WH; Han, PH; Zhang, CX; Zhang, L; Zhang, SQ; Zhou, DC | 1 |
Djakovic, N; Haferkamp, A; Hatiboglu, G; Hohenfellner, M; Hohenfellner, U; Huber, J; Nyarangi-Dix, JN; Schultz-Lampel, D | 1 |
Exter, BP; Jarvis, CI; Melillo, SN; Scanlon, JV; Steinberg, M | 1 |
Aloi, L; Avallone, A; Budillon, A; Comella, P; Delrio, P; Iaffaioli, VR; Iodice, G; Lastoria, S; Marone, P; Pecori, B; Petrillo, A; Sandomenico, C; Scala, D; Scott, N; Tatangelo, F | 1 |
Harber, CR; Nathanson, MH | 1 |
Ananthapavan, J; Diamantopoulos, A; Forster, F; Lees, M; McDonald, H; Wells, PS | 1 |
Alban, S; Völler, H; Westermann, D | 1 |
Clemens, A; Monz, BU; Plumb, JM | 1 |
Crowther, M; Lepic, K | 1 |
Dahl, OE; Huisman, MV; Quinlan, DJ; Schulman, S | 1 |
Chitolie, A; Green, L; Haddad, FS; Hossain, F; Lawrie, AS; Machin, SJ; Mackie, IJ; Patel, S | 1 |
Caglayan, E; Er, F; Erdmann, E; Gassanov, N | 1 |
Alegre, DN; Correia, J; de Almeida, L; Ribeiro, C; Silva, L; Sousa, C | 1 |
Jensen, CD; Muller, SD; Partington, PF; Reed, MR; Steval, A | 1 |
Foote, J; Phillips, SN; Rogers, BA | 1 |
Kwok, CS; Loke, YK | 1 |
Diamantopoulos, A; Lees, M; Lereun, C; Rasul, F; Sengupta, N; Wells, P | 1 |
Giannoudis, PV; Goff, T; Kontakis, G | 1 |
Cerbone, AM; Coppola, A; Franchini, M; Ruosi, C; Tufano, A | 1 |
Ajzenberg, N; Dumont, B; Faille, D | 1 |
Hesse, C; Lindhoff-Last, E; Mani, H; Stratmann, G | 1 |
Galanis, T; Kraft, WK; Merli, GJ | 1 |
Heidinger, K; Kemkes-Matthes, B | 1 |
Alves, C; Batel-Marques, F; Macedo, AF | 1 |
Combe, S; Conard, J; Flaujac, C; Horellou, MH; Samamaa, MM | 1 |
Duggan, ST | 1 |
Migliaccio-Walle, K; Rublee, D; Simon, TA | 1 |
Alpert, JS | 1 |
Cohen, A; Drost, P; Marchant, N; Mitchell, S; Orme, M; Rublee, D; Simon, TA; Sutton, A | 1 |
Cios, D; Fanikos, J | 1 |
Ananthapavan, J; Diamantopoulos, A; Folkerts, K; Forster, F; Lees, M; McDonald, H; Wells, P | 1 |
Belavic, JM | 1 |
Warwick, D | 1 |
Bessereau, J; Bonello, L; Camoin-Jau, L; Paganelli, F; Uhry, S | 1 |
Kwong, LM | 2 |
Freynhofer, MK; Höchtl, T; Huber, K; Mahla, E; Prüller, F | 1 |
Müller, D; Stock, S; Stollenwerk, B; Zindel, S | 1 |
Hui, AC; James, P; Jameson, SS; Muller, SD; Rymaszewska, M; Serrano-Pedraza, I | 1 |
Berkowitz, SD; Eriksson, BI; Gent, M; Homering, M; Kakkar, AK; Lassen, MR; Turpie, AG | 1 |
Lazo-Langner, A; Sun, D | 1 |
Albuquerque, LG; Dini, GM; Ferreira, LM; Ferreira, MCC | 1 |
Kong, Y; Wang, G; Wang, L; Zhang, Y; Zhao, X | 1 |
Alessi, MC; Beguin, S; Bonnet, JL; Castelli, C; Cuisset, T; Fourcade, L; Gaborit, B; Grosdidier, C; Loosveld, M; Morange, PE; Moro, PJ; Quilici, J; Saut, N | 1 |
Guo, W; Tang, BQ; Tang, S; Tang, XD; Yan, TQ; Yang, RL | 1 |
Berkowitz, SD; Homering, M; Llau, JV; Loewe, A; Mueck, W; Rosencher, N | 1 |
Benz, MS; Eifrig, CW; Escalona-Benz, EM; Moore, JK; Murray, TG; Schiffman, JC; Yoder, DM | 1 |
Borris, L; Dahl, OE; Eriksson, BI; Haas, S; Huisman, MV; Kakkar, AK; Kälebo, P; Misselwitz, F | 1 |
Cecconi, F; Del Popolo, G; Filocamo, MT; Li Marzi, V; Marzocco, M; Nicita, G; Villari, D | 1 |
Borris, LC; Dahl, OE; Dierig, C; Eriksson, BI; Haas, S; Huisman, MV; Kakkar, AK; Kälebo, P; Misselwitz, F; Muehlhofer, E | 1 |
Appell, RA; Davila, GW | 1 |
Borris, LC; Dahl, OE; Eriksson, BI; Haas, S; Huisman, MV; Kakkar, AK; Kälebo, P; Misselwitz, F; Muehlhofer, E | 1 |
Kakar, P; Lip, GY; Watson, T | 1 |
Beyer, J; Eriksson, BI; Halbritter, K; Kakkar, AK; Kälebo, P; Misselwitz, F; Schellong, SM; Turpie, AG | 1 |
Buehl, W; Georgopoulos, M; Heinzl, H; Menapace, R; Rainer, G; Wirtitsch, MG | 1 |
Carrión, JM; García, MP; Gómez, ME; Huertas, FR | 1 |
Comez, A; Dogan, OK; Karacan, O; Oral, Y; Ozkurt, Y | 1 |
Fink, KG; Huber, J; Schmeller, NT; Würnschimmel, E | 1 |
Califf, RM; Fox, KA; Mahaffey, KW; Patel, MR; Piccini, JP | 1 |
David, JL; Limet, R; Rigo, P | 1 |
Barbe, G; Gruyer, P; Guyot, L; Lapeyrère, X; Saint-Paul, B | 1 |
Chevigné, M; David, JL; Limet, R; Rigo, P | 1 |
Dohi, S; Mayumi, T | 1 |
Davies, JA; Doig, RL; Kester, RC; McNicol, GP; Menys, VC; Paton, RC; Tindall, H | 1 |
Brommer, EJ | 1 |
Curtet, JM; Guilmet, D; Renner, C | 1 |
Baltatzis, S; Kokolakis, SN; Ladas, ID; Panagiotidis, D; Theodossiadis, GP; Zafirakis, P | 1 |
Jörg, KM; Lachmann, C; Trinkmann, R | 1 |
Hartenbaum, D; Maloney, S; Orillac, R; Sharpe, E; Vacarelli, L; Wilson, H | 1 |
Chakraborty, P; Tinu, AT; Villada, JR | 1 |
Dick, HB; Krummenauer, F; Schwenn, O; Xia, N | 1 |
Dios Castro, E; Maquet Dusart, JA | 1 |
Seal, DV; Strangeways, JE | 1 |
Huber, R; Lühmann, R; Prügner, W | 1 |
Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A; Tsurumi, T | 1 |
Harker, LA | 1 |
Goebel, N; Krayenbühl, HP; Pfluger, N; Rothlin, ME; Senning, A; Speiser, K; Steinbrunn, W; Turina, M | 1 |
Gröntoft, KC; Gutierrez, A; Mulec, H; Olander, R | 1 |
Takayama, T | 1 |
Avello, F; Carmona, J; Criado, A; Juffé, A; Otero, C | 1 |
Bishara, A; Narshy, W; Zayed, H | 1 |
Caja, R; Francillon, J; Perrin, F | 1 |
Henkin, RI; Hoye, RC; Ketcham, AS | 1 |
40 review(s) available for thiophenes and Complication, Postoperative
Article | Year |
---|---|
[Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Rivaroxaban is as efficient and safe as bemiparin as thromboprophylaxis in knee arthroscopy.
Topics: Adult; Aged; Arthroscopy; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Knee Joint; Male; Middle Aged; Morpholines; Polypharmacy; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Rivaroxaban; Therapeutic Equipoise; Thiophenes; Thrombophilia; Venous Thrombosis | 2014 |
[New clinical perspectives in the management of oral direct anticoagulant agents].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Elective Surgical Procedures; Emergencies; Factor Xa Inhibitors; Hemorrhage; Humans; Kidney Diseases; Morpholines; Orthopedic Procedures; Postoperative Complications; Premedication; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K | 2014 |
Novel oral anticoagulants: a review of new agents.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2013 |
The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2013 |
Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Blood Coagulation Tests; Clinical Trials, Phase III as Topic; Contraindications; Dabigatran; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Hematoma, Epidural, Spinal; Humans; Morpholines; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2013 |
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Ticagrelor | 2014 |
[Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Benzamides; Blood Coagulation; Embolism; Factor Xa Inhibitors; Hemorrhage; Hemostatics; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombophilia; Thrombosis | 2014 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
A systematic review and adjusted indirect comparison of oral anticoagulants.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2014 |
Periprocedural management of rivaroxaban-treated patients.
Topics: Administration, Oral; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Perioperative Period; Postoperative Complications; Risk; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Thromboembolism | 2015 |
[Rivaroxaban. The first factor Xa inhibitor].
Topics: Animals; Factor Xa Inhibitors; Heart Diseases; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis | 2008 |
[Anaesthesia and thromboembolic disease].
Topics: Acenocoumarol; Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; Clinical Protocols; Dabigatran; Early Ambulation; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Risk Factors; Rivaroxaban; Safety; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2008 |
[Rivaroxaban: clinical pharmacology].
Topics: Administration, Oral; Aged; Anticoagulants; Biological Availability; Clinical Trials as Topic; Contraindications; Cytochrome P-450 CYP3A; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Metabolic Clearance Rate; Middle Aged; Molecular Structure; Morpholines; Orthopedic Procedures; Postoperative Complications; Preanesthetic Medication; Rivaroxaban; Thiophenes; Venous Thrombosis | 2008 |
[Perioperative venous thromboembolism prophylaxis: short review and recommendations].
Topics: Adult; Aged; Anticoagulants; Combined Modality Therapy; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Morpholines; Polysaccharides; Postoperative Complications; Preanesthetic Medication; Pulmonary Embolism; Risk Factors; Rivaroxaban; Stockings, Compression; Thiophenes; Thromboembolism; Thrombophlebitis; Vitamin K | 2008 |
[Rivaroxaban (Xarelto): efficacy and safety].
Topics: Administration, Oral; Anticoagulants; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hematoma, Epidural, Spinal; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Morpholines; Postoperative Complications; Preanesthetic Medication; Rivaroxaban; Thiophenes; Thromboembolism | 2008 |
[Rivaroxaban: mode of action].
Topics: Administration, Oral; Anticoagulants; Clinical Trials as Topic; Drug Administration Schedule; Drug Monitoring; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Molecular Structure; Morpholines; Postoperative Complications; Preanesthetic Medication; Prothrombin Time; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism; Vitamin K; Warfarin | 2008 |
Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty.
Topics: Administration, Oral; Animals; Antithrombin III; Arthroplasty; Clinical Trials as Topic; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Thrombolytic Therapy | 2009 |
A logical approach to surgical thromboprophylaxis.
Topics: Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Premedication; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2009 |
Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cost-Benefit Analysis; Humans; Morpholines; Postoperative Complications; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2009 |
Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery.
Topics: Animals; Clinical Trials, Phase III as Topic; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Canada; Cost-Benefit Analysis; Enoxaparin; Follow-Up Studies; Humans; Morpholines; Postoperative Complications; Quality of Life; Rivaroxaban; Sensitivity and Specificity; Thiophenes; Venous Thromboembolism | 2010 |
[New oral anticoagulants: better than vitamin K antagonists?].
Topics: Anticoagulants; Antithrombin Proteins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis; Vitamin K | 2010 |
New anticoagulants for the prevention of thromboembolism.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2011 |
New anticoagulants: pharmacology and clinical studies.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Postoperative Complications; Prothrombin; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2011 |
Safety and efficacy of rivaroxaban for thromboprophylaxis following lower limb surgery: an update.
Topics: Anticoagulants; Clinical Trials, Phase III as Topic; Humans; Lower Extremity; Morpholines; Orthopedics; Postoperative Complications; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2011 |
Preventing postsurgical venous thromboembolism: pharmacological approaches.
Topics: Aged; Anticoagulants; Antithrombins; Arthroscopy; Bariatric Surgery; Benzimidazoles; Blood Coagulation Disorders, Inherited; Dabigatran; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Kidney; Knee; Laparoscopy; Morpholines; Neoplasms; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thrombophilia; Venous Thromboembolism | 2011 |
[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Approval; Drug Monitoring; Factor Xa Inhibitors; Fibrinolytic Agents; Forecasting; France; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Thrombophilia; Venous Thromboembolism | 2011 |
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Neurosurgical Procedures; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stockings, Compression; Surgical Procedures, Operative; Thiophenes; Urologic Surgical Procedures; Venous Thrombosis | 2011 |
[New anticoagulants. Characteristics, monitoring and management of bleeding].
Topics: Administration, Oral; Antithrombins; Arthroplasty, Replacement, Hip; Atrial Fibrillation; Benzimidazoles; Blood Coagulation Tests; Critical Care; Dabigatran; Drug Approval; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K | 2011 |
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis | 2012 |
Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis.
Topics: Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Resistance; Evidence-Based Medicine; Genotype; Humans; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine | 2012 |
[Platelet function: new drugs, new assays : possible impacts on operative medicine?].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Postoperative Complications; Postoperative Hemorrhage; Practice Guidelines as Topic; Prasugrel Hydrochloride; Predictive Value of Tests; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine | 2012 |
Treatment options for patients with suboptimal response to surgery for stress urinary incontinence.
Topics: Adrenergic Antagonists; Antidepressive Agents, Tricyclic; Biofeedback, Psychology; Case Management; Collagen; Duloxetine Hydrochloride; Estrogen Replacement Therapy; Exercise Therapy; Female; Humans; Injections; Pessaries; Postoperative Complications; Prostheses and Implants; Quality of Life; Radiofrequency Therapy; Reoperation; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2007 |
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.
Topics: Administration, Oral; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Humans; Molecular Structure; Morpholines; Patents as Topic; Postoperative Complications; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thromboembolism | 2007 |
Rivaroxaban, an oral direct factor Xa inhibitor.
Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Animals; Anticoagulants; Atrial Fibrillation; Binding Sites; Clinical Trials as Topic; Comorbidity; Drug Evaluation, Preclinical; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Rats; Rivaroxaban; Stroke; Thiophenes; Thrombosis; Warfarin | 2008 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
33 trial(s) available for thiophenes and Complication, Postoperative
Article | Year |
---|---|
Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Arthroplasty, Replacement, Hip; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Patient Safety; Postoperative Complications; Risk; Rivaroxaban; Thiophenes; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2013 |
Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost of Illness; Cost-Benefit Analysis; Dabigatran; Direct Service Costs; Enoxaparin; France; Humans; Italy; Models, Theoretical; Morpholines; Postoperative Complications; Pyridines; Quality of Life; Rivaroxaban; Spain; Thiophenes; Venous Thromboembolism | 2013 |
Efficacy and safety of rivaroxaban versus low-molecular-weight heparin therapy in patients with lower limb fractures.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Factor Xa Inhibitors; Female; Fractures, Bone; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Length of Stay; Lower Extremity; Male; Middle Aged; Morpholines; Postoperative Complications; Retrospective Studies; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2014 |
[Case-control study on effect of rivaroxaban on the risk of hidden bleeding after total hip arthroplasty].
Topics: Arthroplasty, Replacement, Hip; Case-Control Studies; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Risk; Rivaroxaban; Thiophenes; Time Factors | 2014 |
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP2C19; Double-Blind Method; Elective Surgical Procedures; Female; Follow-Up Studies; Gene Frequency; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Ticlopidine | 2014 |
Effects of perioperative topical dorzolamide hydrochloride-timolol maleate administration on incidence and severity of postoperative ocular hypertension in dogs undergoing cataract extraction by phacoemulsification.
Topics: Animals; Antihypertensive Agents; Cataract Extraction; Dog Diseases; Dogs; Drug Combinations; Ocular Hypertension; Perioperative Care; Postoperative Complications; Sulfonamides; Thiophenes; Timolol | 2016 |
Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics.
Topics: Aged; Cardiopulmonary Bypass; Endothelin A Receptor Antagonists; Female; Hemodynamics; Humans; Isoxazoles; Male; Middle Aged; Postoperative Complications; Postoperative Period; Prospective Studies; Risk Factors; Single-Blind Method; Thiophenes; Time Factors; Ventricular Dysfunction, Left | 2010 |
Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Canada; Cost-Benefit Analysis; Enoxaparin; Follow-Up Studies; Humans; Morpholines; Postoperative Complications; Quality of Life; Rivaroxaban; Sensitivity and Specificity; Thiophenes; Venous Thromboembolism | 2010 |
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Follow-Up Studies; Hemorrhage; Humans; Morpholines; Postoperative Complications; Prospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Withholding Treatment | 2010 |
The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dalteparin; Factor Xa; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Rivaroxaban; Thiophenes; Thrombin; Treatment Outcome; Venous Thromboembolism | 2010 |
How safe is thromboprophylaxis in abdominoplasty?
Topics: Abdominoplasty; Administration, Oral; Adult; Anticoagulants; Double-Blind Method; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Follow-Up Studies; Hematoma; Humans; Middle Aged; Morpholines; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2012 |
[Evaluation of efficacy and safety of rivaroxaban in the prevention of postoperative venous thromboembolism in adult patients with primary bone tumor undergoing knee operation].
Topics: Adult; Anticoagulants; Bone Neoplasms; Female; Humans; Knee; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Young Adult | 2012 |
Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin).
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Enoxaparin; Female; Hematoma; Humans; Incidence; Male; Middle Aged; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2013 |
Immediate postoperative use of a topical agent to prevent intraocular pressure elevation after pars plana vitrectomy with gas tamponade.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Therapy, Combination; Female; Fluorocarbons; Humans; Intraocular Pressure; Male; Middle Aged; Postoperative Complications; Postoperative Period; Prospective Studies; Retinal Detachment; Retinal Perforations; Sulfonamides; Sulfur Hexafluoride; Thiophenes; Timolol; Vitrectomy | 2004 |
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Dose-Response Relationship, Drug; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis | 2006 |
Pharmacologic treatment in postprostatectomy stress urinary incontinence.
Topics: Adrenergic Uptake Inhibitors; Aged; Analysis of Variance; Combined Modality Therapy; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Quality of Life; Statistics, Nonparametric; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2007 |
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
Topics: Administration, Oral; Adult; Anticoagulants; Arthroplasty, Replacement, Hip; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Postmenopause; Postoperative Complications; Rivaroxaban; Safety; Sample Size; Survival Analysis; Thiophenes | 2006 |
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Phlebography; Postoperative Complications; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis | 2007 |
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.
Topics: Anticoagulants; Enoxaparin; Hip Prosthesis; Humans; Knee Prosthesis; Morpholines; Orthopedic Procedures; Phlebography; Postoperative Complications; Rivaroxaban; Sensitivity and Specificity; Thiophenes; Ultrasonography; Venous Thrombosis | 2007 |
Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination: randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Capsulorhexis; Cataract; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Lenses, Intraocular; Male; Middle Aged; Ocular Hypertension; Postoperative Complications; Prospective Studies; Prosthesis Design; Sulfonamides; Thiophenes; Timolol | 2007 |
Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Ocular Hypertension; Phacoemulsification; Postoperative Care; Postoperative Complications; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2008 |
The use of Duloxetine in the treatment of male stress urinary incontinence.
Topics: Adrenergic Uptake Inhibitors; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Patient Satisfaction; Postoperative Complications; Prostatectomy; Selective Serotonin Reuptake Inhibitors; Thiophenes; Transurethral Resection of Prostate; Urinary Incontinence, Stress | 2008 |
Ticlopidine and coronary surgery.
Topics: Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Humans; Postoperative Complications; Thiophenes; Ticlopidine | 1984 |
The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.
Topics: Bleeding Time; Hemorrhage; Humans; Male; Platelet Function Tests; Postoperative Complications; Prostatectomy; Pyridines; Random Allocation; Thiophenes; Thrombophlebitis; Ticlopidine | 1981 |
[Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Cardiac Surgical Procedures; Extracorporeal Circulation; Humans; Middle Aged; Platelet Aggregation; Postoperative Complications; Pyridines; Thiophenes; Thrombocytopenia; Thrombosis; Ticlopidine | 1980 |
Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cataract Extraction; Double-Blind Method; Female; Follow-Up Studies; Humans; Intraocular Pressure; Laser Therapy; Lens Capsule, Crystalline; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Safety; Sulfonamides; Thiophenes; Treatment Outcome | 1997 |
[Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
Topics: Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cataract Extraction; Double-Blind Method; Female; Humans; Intraocular Pressure; Laser Therapy; Male; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Premedication; Sulfonamides; Thiophenes; Treatment Outcome | 1998 |
A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
Topics: Anterior Eye Segment; Carbonic Anhydrase Inhibitors; Double-Blind Method; Humans; Intraocular Pressure; Laser Therapy; Ocular Hypertension; Ophthalmic Solutions; Postoperative Complications; Sulfonamides; Thiophenes | 1999 |
[Prevention of early postoperative increase in intraocular pressure after phacoemulsification. Comparison of different antiglaucoma drugs].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Polysaccharides, Bacterial; Postoperative Care; Postoperative Complications; Quinoxalines; Sulfonamides; Thiophenes; Time Factors; Timolol | 2001 |
Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects.
Topics: Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Edema; Female; Horse Diseases; Horses; Inflammation; Lameness, Animal; Male; Orchiectomy; Pain; Postoperative Complications; Thiophenes | 1991 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion.
Topics: Acenocoumarol; Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Graft Occlusion, Vascular; Humans; Middle Aged; Postoperative Complications; Thiophenes; Ticlopidine | 1985 |
Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.
Topics: Adult; Aged; Anticoagulants; Arteriovenous Shunt, Surgical; Clinical Trials as Topic; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Postoperative Complications; Renal Dialysis; Thiophenes; Thrombosis; Ticlopidine | 1985 |
73 other study(ies) available for thiophenes and Complication, Postoperative
Article | Year |
---|---|
The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice.
Topics: Administration, Oral; Animals; Cell Movement; Cells, Cultured; Disease Models, Animal; Female; Fibroblasts; Fibrosis; Humans; Imidazoles; Injections, Intraperitoneal; Mice; Peritoneum; Postoperative Care; Postoperative Complications; Primary Cell Culture; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes; Tissue Adhesions; Transforming Growth Factor beta; Wound Healing | 2020 |
Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy.
Topics: Actins; Animals; Blotting, Western; Cell Proliferation; Conjunctiva; Disease Models, Animal; Female; Fibroblasts; Fibronectins; Fibrosis; Forkhead Box Protein M1; Glaucoma; In Situ Nick-End Labeling; Injections, Intraocular; Intraocular Pressure; Male; Postoperative Complications; Pyridines; Rabbits; Real-Time Polymerase Chain Reaction; Tenon Capsule; Thiophenes; Trabeculectomy; Transforming Growth Factor beta1; Wound Healing | 2021 |
Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chemoprevention; Elective Surgical Procedures; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Osteoarthritis, Hip; Osteoarthritis, Knee; Outcome and Process Assessment, Health Care; Postoperative Complications; Rivaroxaban; Thiophenes; United Kingdom; Venous Thromboembolism; Wound Healing | 2013 |
The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Case-Control Studies; Female; Follow-Up Studies; Humans; Middle Aged; Morpholines; Postoperative Complications; Primary Prevention; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Rivaroxaban; Survival Rate; Thiophenes; Time Factors; Treatment Outcome; Venous Thromboembolism | 2013 |
Factors affecting residual platelet aggregation in prasugrel treated patients.
Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Cohort Studies; Drug Resistance; Female; Heart Diseases; Hemorrhage; Humans; Maintenance Chemotherapy; Male; Middle Aged; Models, Biological; Myocardial Ischemia; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Smoking; Thiophenes | 2013 |
[Comparison of effects of two anticoagulants on hidden blood loss after total hip arthroplasty].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Volume; Enoxaparin; Female; Femur Head Necrosis; Humans; Injections, Subcutaneous; Male; Middle Aged; Morpholines; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Rivaroxaban; Thiophenes; Young Adult | 2013 |
Severe postoperative hyperthermic syndrome after addition of tilidine/naloxone to duloxetine therapy.
Topics: Aged; Analgesics; Brain; Drug Interactions; Duloxetine Hydrochloride; Female; Fever; Humans; Magnetic Resonance Imaging; Naloxone; Narcotic Antagonists; Narcotics; Neuroimaging; Postoperative Complications; Thiophenes; Tilidine | 2013 |
Perioperative management of patients who are receiving a novel oral anticoagulant.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Male; Morpholines; Perioperative Care; Postoperative Complications; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism | 2013 |
A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching.
Topics: Angioplasty; Antithrombins; Clopidogrel; Cohort Studies; Drug Combinations; Female; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Piperazines; Postoperative Complications; Prasugrel Hydrochloride; Recombinant Proteins; Retrospective Studies; Thiophenes; Thrombosis; Ticlopidine | 2013 |
Pharmacogenetic workup of perioperative serotonin syndrome.
Topics: Anesthesia, General; Cytochrome P-450 CYP2D6; Drug Interactions; Duloxetine Hydrochloride; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Postoperative Complications; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Thiophenes | 2013 |
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Substitution; Female; Genetic Testing; Genotype; Health Personnel; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Sequence Deletion; Thiophenes; Ticlopidine | 2013 |
Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Automation, Laboratory; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Equipment and Supplies; Factor VII; Hemorrhage; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Stroke; Thiophenes; Thrombelastography; Thrombin; Thrombin Time; Venous Thrombosis; Withholding Treatment | 2014 |
Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Perioperative Period; Postoperative Complications; Prospective Studies; Registries; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome | 2014 |
[Comparison of rivaroxaban and enoxaparin on blood loss after total knee arthroplasty].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Volume; Enoxaparin; Female; Humans; Male; Middle Aged; Morpholines; Osteoarthritis, Knee; Postoperative Complications; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; Treatment Outcome | 2014 |
Measurement of rivaroxaban and apixaban in serum samples of patients.
Topics: Administration, Oral; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Biological Assay; Case-Control Studies; Chromogenic Compounds; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Serum; Specimen Handling; Thiophenes; Thromboembolism | 2014 |
Development of delayed cardiac tamponade 55 days after catheter ablation for atrial fibrillation with a new oral anticoagulant.
Topics: Aged; Atrial Fibrillation; Cardiac Tamponade; Catheter Ablation; Echocardiography, Doppler; Follow-Up Studies; Humans; Male; Morpholines; Pericardiocentesis; Pleural Effusion; Postoperative Complications; Rare Diseases; Rivaroxaban; Thiophenes; Time Factors; Treatment Outcome | 2014 |
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
Topics: Acute Disease; Age Factors; Aged; Clopidogrel; Drug Substitution; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Postoperative Complications; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Recurrence; Registries; Risk Factors; Thiophenes; Thrombosis; Ticlopidine; United States | 2014 |
Perioperative dorzolamide-timolol intervention for rising intraocular pressure during steep Trendelenburg positioned surgery.
Topics: Adult; Aged; Anesthesia; Antihypertensive Agents; Blindness; Drug Combinations; Female; Head-Down Tilt; Humans; Laparoscopy; Male; Middle Aged; New England; Ocular Hypertension; Ophthalmic Solutions; Perioperative Care; Postoperative Complications; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2014 |
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Combined Modality Therapy; Dabigatran; Female; Heparin; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Radio Waves; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin | 2014 |
[Safety and efficacy of rivaroxaban for prevention of deep vein thrombosis in patients with preoperative abnormal D-dimer after total knee arthroplasty].
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Humans; Knee Joint; Length of Stay; Morpholines; Osteoarthritis, Knee; Postoperative Complications; Postoperative Period; Preoperative Care; Prothrombin Time; Range of Motion, Articular; Rivaroxaban; Safety; Thiophenes; Venous Thrombosis | 2014 |
[Aspects of the practical application of direct oral anticoagulants in traumatological and orthopedic hospital].
Topics: Administration, Oral; Anticoagulants; Chemoprevention; Costs and Cost Analysis; Humans; Morpholines; Orthopedic Procedures; Orthopedics; Outcome Assessment, Health Care; Postoperative Complications; Retrospective Studies; Rivaroxaban; Russia; Secondary Prevention; Thiophenes; Traumatology; Venous Thromboembolism | 2014 |
Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells.
Topics: Acute Disease; Cell Cycle Proteins; Cell Growth Processes; Cell Line, Tumor; Graft vs Host Disease; HSP90 Heat-Shock Proteins; Humans; Immunologic Memory; Isoantigens; Leukemia; Lymphocyte Activation; Lymphocyte Depletion; Molecular Targeted Therapy; Polo-Like Kinase 1; Postoperative Complications; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Stem Cell Transplantation; T-Lymphocyte Subsets; T-Lymphocytes; Thiophenes; Transplantation, Homologous | 2016 |
Effect of prophylactic topical hypotensive medications in reducing the incidence of postoperative ocular hypertension after phacoemulsification in dogs.
Topics: Administration, Topical; Animals; Dog Diseases; Dogs; Female; Incidence; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Pre-Exposure Prophylaxis; Prostaglandins F, Synthetic; Retrospective Studies; Sulfonamides; Thiophenes; Timolol | 2017 |
Selective factor Xa inhibition for thromboprophylaxis.
Topics: Anticoagulants; Clinical Trials as Topic; Enoxaparin; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2008 |
[Rivaroxaban: a decisive step forward in the management of postoperative thromboembolic disease?].
Topics: Fibrinolytic Agents; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Thromboembolism | 2008 |
[Summary and perspectives. Rivaroxaban].
Topics: Administration, Oral; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Comorbidity; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; Kidney Failure, Chronic; Morpholines; Obesity; Postoperative Complications; Preanesthetic Medication; Rivaroxaban; Thiophenes; Thromboembolism; Thrombophilia; Venous Thrombosis | 2008 |
The novel anticoagulants: entering a new era.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombolytic Therapy; Vitamin K | 2009 |
Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Elective Surgical Procedures; Humans; Morpholines; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
Topics: Humans; Morpholines; Orthopedics; Postoperative Complications; Premedication; Rivaroxaban; Thiophenes; Thrombosis; Treatment Outcome | 2009 |
P2Y12 inhibitors: thienopyridines and direct oral inhibitors.
Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Aspirin; Atherosclerosis; Coronary Artery Bypass; Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stroke; Thiophenes; Ticagrelor | 2009 |
New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
Topics: Anticoagulants; Benzimidazoles; Dabigatran; Enoxaparin; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2009 |
[Prophylaxis of venous thromboembolism in orthopaedic surgery--trivial option, huge potential].
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Coagulation Tests; Combined Modality Therapy; Drug Approval; Drug Interactions; Early Ambulation; Enoxaparin; Factor Xa Inhibitors; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Orthopedic Procedures; Postoperative Care; Postoperative Complications; Practice Guidelines as Topic; Rivaroxaban; Stockings, Compression; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2010 |
[Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass].
Topics: Acute Lung Injury; Animals; Cardiopulmonary Bypass; Disease Models, Animal; Dogs; Lung; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Phenylalanine; Postoperative Complications; Thiophenes | 2010 |
[Conservative management of postoperative urinary incontinence in men].
Topics: Adrenergic Uptake Inhibitors; Biofeedback, Psychology; Combined Modality Therapy; Duloxetine Hydrochloride; Electric Stimulation Therapy; Exercise Therapy; Humans; Magnetic Field Therapy; Male; Postoperative Complications; Prostatectomy; Thiophenes; Urinary Incontinence, Stress | 2010 |
Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diarrhea; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Preoperative Care; Prognosis; Quinazolines; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Thiophenes; Thymidylate Synthase; Treatment Outcome; Vitamin B Complex | 2011 |
Rivaroxaban for thromboembolism prophylaxis after orthopaedic surgery.
Topics: Fibrinolytic Agents; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Practice Guidelines as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Dabigatran; Enoxaparin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Models, Economic; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Quality-Adjusted Life Years; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2010 |
[Prophylaxis of thrombembolic diseases with rivaroxaban].
Topics: Administration, Oral; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biological Availability; Dose-Response Relationship, Drug; Drug Interactions; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Metabolic Clearance Rate; Morpholines; Partial Thromboplastin Time; Postoperative Complications; Protein Binding; Prothrombin Time; Rivaroxaban; Thiophenes; Thromboembolism | 2010 |
Possible benefits of strontium ranelate in complicated long bone fractures.
Topics: Adult; Bone Density Conservation Agents; Female; Femoral Fractures; Fracture Healing; Fractures, Bone; Humans; Male; Middle Aged; Organometallic Compounds; Osteotomy; Postoperative Complications; Radiography; Radius Fractures; Strontium; Thiophenes; Tibial Fractures | 2012 |
Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Morpholines; Postoperative Care; Postoperative Complications; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Rivaroxaban; Thiophenes; Thromboembolism; Tinzaparin | 2011 |
Rivaroxaban for thromboembolism prophylaxis after orthopaedic surgery.
Topics: Arthroplasty, Replacement, Hip; Drug Administration Schedule; Fibrinolytic Agents; Humans; Morpholines; Postoperative Care; Postoperative Complications; Retrospective Studies; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Female; Health Care Costs; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Risk; Risk Factors; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2011 |
Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time.
Topics: Aged; Anticoagulants; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Clinical Protocols; Drug Interactions; Factor Xa Inhibitors; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Orthopedic Procedures; Postoperative Complications; Rivaroxaban; Thiophenes; Time Factors; Venous Thromboembolism | 2011 |
Xarelto: a new drug for new joints. Hip and knee recipients can avoid postsurgical clots without undergoing painful injections.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Embolism; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Thrombosis | 2011 |
[Pharmacologic heterogeneity of new anticoagulants].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Approval; Humans; Kidney; Liver; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; United States; United States Food and Drug Administration | 2011 |
Anticoagulation prophylaxis in orthopedic surgery: an efficiency frontier approach.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Decision Trees; Drug Costs; Elective Surgical Procedures; Enoxaparin; Female; Humans; Male; Markov Chains; Models, Economic; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; State Medicine; Thiophenes; United Kingdom; Venous Thromboembolism | 2012 |
New directions in anticoagulation.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2012 |
Rivaroxaban to prevent pulmonary embolism after hip or knee replacement.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug Interactions; Humans; Morpholines; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes | 2012 |
Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Cost-Benefit Analysis; Humans; Morpholines; Ontario; Postoperative Complications; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Rivaroxaban for thromboprophylaxis after hip or knee replacement surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug Interactions; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Prevention of venous thromboembolism in total knee and hip replacement.
Topics: Aged; Anesthesia, Conduction; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Drug Administration Schedule; Female; Hip Prosthesis; Humans; Morpholines; Obesity; Postoperative Complications; Postoperative Hemorrhage; Practice Guidelines as Topic; Premedication; Prosthesis Failure; Recurrence; Reoperation; Risk; Risk Factors; Rivaroxaban; Stockings, Compression; Thiophenes; Venous Thromboembolism | 2012 |
Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2012 |
A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cost-Benefit Analysis; Databases, Factual; Decision Trees; Enoxaparin; Germany; Humans; Morpholines; Multicenter Studies as Topic; National Health Programs; Postoperative Complications; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
Topics: Age Distribution; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cerebral Hemorrhage; Cohort Studies; Confidence Intervals; Databases, Factual; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Morpholines; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Assessment; Rivaroxaban; Sex Distribution; Surgical Wound Infection; Survival Analysis; Thiophenes; Treatment Outcome; Venous Thrombosis; Wound Healing | 2012 |
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
Topics: Anticoagulants; Arthroplasty, Replacement, Ankle; Arthroplasty, Replacement, Knee; Clinical Trials, Phase III as Topic; Enoxaparin; Hemarthrosis; Hemorrhage; Humans; Morpholines; Postoperative Complications; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2012 |
Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.
Topics: Factor Xa Inhibitors; Humans; Morpholines; Postoperative Complications; Thiophenes; Venous Thromboembolism | 2012 |
New oral anticoagulants.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Canada; Contraindications; Dabigatran; Drug Dosage Calculations; Drug Interactions; Humans; Morpholines; Postoperative Complications; Pyridines; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2013 |
[Impact of ivaroxaban on hidden blood loss and blood transfusion rate after primary total knee arthroplasty].
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Transfusion; Female; Hemoglobins; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Morpholines; Osteoarthritis, Knee; Postoperative Complications; Postoperative Hemorrhage; Range of Motion, Articular; Retrospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thrombosis | 2012 |
CYP2C19*2 and *17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Alleles; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Cytochrome P-450 CYP2C19; Female; Hemorrhage; Humans; Male; Middle Aged; Piperazines; Postoperative Complications; Prasugrel Hydrochloride; Prospective Studies; Risk Factors; Thiophenes | 2012 |
[Acute closed-angle glaucoma after gynecological surgery under general anesthesia].
Topics: Acetazolamide; Acute Disease; Anesthesia, General; Atropine; Combined Modality Therapy; Corneal Edema; Dexamethasone; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Laser Therapy; Mannitol; Middle Aged; Mydriasis; Pilocarpine; Postoperative Complications; Sulfonamides; Thiophenes; Timolol; Vomiting | 2007 |
[Comparative action of different platelet anti-aggregants in the postoperative period].
Topics: Anticoagulants; Dipyridamole; Humans; Papaverine; Parasympatholytics; Platelet Aggregation; Postoperative Complications; Postoperative Period; Thiophenes; Thrombophlebitis; Ticlopidine | 1984 |
Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study.
Topics: Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Complications; Radiography; Random Allocation; Saphenous Vein; Thiophenes; Ticlopidine | 1984 |
Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy.
Topics: Aged; Anesthesia, Spinal; Anticoagulants; Female; Hematoma; Humans; Postoperative Complications; Spinal Cord Diseases; Spinal Puncture; Subarachnoid Hemorrhage; Thiophenes; Ticlopidine | 1983 |
Platelet survival in patients treated with ticlopidine following reconstructive arterial surgery.
Topics: Aged; Aorta; Blood Platelets; Blood Vessel Prosthesis; Cell Survival; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Postoperative Complications; Thiophenes; Ticlopidine | 1982 |
A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification. 1999; 43 (5): 344-6.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Carbonic Anhydrase Inhibitors; Humans; Intraocular Pressure; Phacoemulsification; Postoperative Complications; Sulfonamides; Thiophenes | 1999 |
[Weill-Marchesani syndrome. Late athalamia following antiglaucomatous surgery].
Topics: Abnormalities, Multiple; Adult; Cataract Extraction; Combined Modality Therapy; Drug Resistance; Dwarfism; Female; Fingers; Glaucoma, Angle-Closure; Hand Deformities, Congenital; Humans; Intraocular Pressure; Iridectomy; Lens Implantation, Intraocular; Lens, Crystalline; Mitomycins; Phacoemulsification; Postoperative Complications; Sulfonamides; Syndrome; Thiophenes; Trabeculectomy; Vitrectomy | 2002 |
Letter: Resistant pseudomonads in a neurosurgical unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriuria; Carbenicillin; Carboxylic Acids; Cross Infection; Gentamicins; Hospital Units; Humans; Neurosurgery; Penicillin Resistance; Penicillins; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Thiophenes; Urinary Catheterization | 1975 |
[Abnormalities of blood coagulation and effect of anticoagulant therapy in postoperative patients with lung cancer].
Topics: Adult; Aged; Anticoagulants; beta-Thromboglobulin; Blood Coagulation Disorders; Female; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Thiophenes; Ticlopidine; Warfarin | 1986 |
[Antithrombogenic therapy based on the study of the changes in platelet aggregability and blood coagulability in the early period after prosthetic valve replacement].
Topics: Adult; Anticoagulants; Blood Coagulation; Dipyridamole; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Thiophenes; Thrombosis; Ticlopidine; Warfarin | 1985 |
Ticlopidine as a hemorrhagic risk factor in coronary surgery.
Topics: Adult; Coronary Disease; Female; Hemorrhage; Humans; Male; Platelet Aggregation; Platelet Count; Postoperative Complications; Retrospective Studies; Risk; Thiophenes; Ticlopidine | 1985 |
Anaesthesia for perineal prostatectomy.
Topics: Anesthesia; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Spinal; Atropine; Blood Pressure; Heart Rate; Humans; Infusions, Parenteral; Male; Mepivacaine; Nitrous Oxide; Postoperative Complications; Prostatectomy; Succinylcholine; Thiophenes; Time Factors; Tubocurarine | 1974 |
[Place of high dose Visceralgine in general and gynecologic surgery].
Topics: Adolescent; Adult; Aged; Analgesics; Female; Genital Diseases, Female; Humans; Hysterosalpingography; Iodine; Middle Aged; Morpholines; Parasympatholytics; Postoperative Complications; Thiophenes | 1971 |
Hyposmia after paranasal sinus exenteration of laryngectomy.
Topics: Child; Epithelium; Female; Humans; Laryngectomy; Limbic System; Male; Middle Aged; Nitrobenzenes; Odorants; Olfaction Disorders; Olfactory Nerve; Paranasal Sinuses; Postoperative Complications; Pyridines; Smell; Thiophenes | 1970 |